The Oncology Institute Entered Into A Securities Purchase Agreement With Accredited Investors For A Private Placement In Gross Proceeds Of Approximately $16.5M

Author: Benzinga Newsdesk | March 24, 2025 06:08am

Pursuant to the terms of the Securities Purchase Agreement, the Company will issue to purchasers in the Private Placement units consisting of two shares of common stock (or pre-funded warrants in lieu thereof) and common warrants to purchase one share of common stock (or pre-funded warrants) of the Company at a price of $2.2084 per unit (or $2.2082 in the case of units consisting of pre-funded warrants). The pre-funded warrants will have an exercise price of $0.0001 per share until exercised in full, and the common warrants will have an exercise price of $1.1980 per share. 

Posted In: TOI